Luminus Management LLC Rain Therapeutics Inc. Transaction History

Luminus Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$5.07 - $13.68 $696,759 - $1.88 Million	-137,428 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.21 - $20.91 $3.8 Million - $6.01 Million	-287,572 Reduced 67.66%	137,428 $2.06 Million
Q2 2021 Aug 16, 2021	BUY	$15.08 - $20.3 $6.41 Million - $8.63 Million	425,000 New	425,000 $6.61 Million

122K

Ticker RAIN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,837,400
Description
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in...

Get notified when there are updates to the investment portfolio of Luminus Management LLC, based on Form 13F filings with the SEC.

Stay updated on Luminus Management LLC with notifications on news.